Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

Hermans, Cédric; Eeckhoudt, Stéphane; Lambert, Catherine

doi:10.1160/TH11-11-0788

Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

Hermans, Cédric

;

Eeckhoudt, Stéphane

;

Lambert, Catherine

(2012) Thrombosis and Haemostasis : international journal for vascular biology and medicine — Vol. 107, n° 6, p. 1189-1191 (2012)

Files

No attached file found for this publication.

Details

Authors

Hermans, CédricUCLouvain
Author
Eeckhoudt, StéphaneUCLouvain
Author
Lambert, CatherineUCLouvain
Author

Affiliations

UCLouvainSSS/IREC/CARD - Pôle de recherche cardiovasculaire
UCLouvain(SLuc) Service d'hématologie
UCLouvain(SLuc) Service de biologie hématologique

Citations

APA
Chicago
FWB

Hermans, C., Eeckhoudt, S., & Lambert, C. (2012). Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency. Thrombosis and Haemostasis : international journal for vascular biology and medicine, 107(6), 1189-1191. https://doi.org/10.1160/TH11-11-0788 (Original work published 2012)